Andere Kunden interessierten sich auch für
![Controlled Release Injection of a Central Nervous System Acting Drug]( "Controlled Release Injection of a Central Nervous System Acting Drug")
Controlled Release Injection of a Central Nervous System Acting Drug53,99 €![Needle free injection technology]( "Needle free injection technology")
Needle free injection technology32,99 €![Process Validation of Ceftriaxone Sodium Dry Injection]( "Process Validation of Ceftriaxone Sodium Dry Injection")
Process Validation of Ceftriaxone Sodium Dry Injection32,99 €![Report On the Effects of Artificial Respiration, Intravenous Injection of Ammonia, and Administration of Various Drugs, &C. in Indian and Australian Snake-Poisoning, and the Physiological, Chemical, and Microscopical Nature of Snake-Poisons]( "Report On the Effects of Artificial Respiration, Intravenous Injection of Ammonia, and Administration of Various Drugs, &C. in Indian and Australian Snake-Poisoning, and the Physiological, Chemical, and Microscopical Nature of Snake-Poisons")
Report On the Effects of Artificial Respiration, Intravenous Injection of Ammonia, and Administration of Various Drugs, &C. in Indian and Australian Snake-Poisoning, and the Physiological, Chemical, and Microscopical Nature of Snake-Poisons34,99 €![Formulation and Evaluation of Albendazole Tablet]( "Formulation and Evaluation of Albendazole Tablet")
Formulation and Evaluation of Albendazole Tablet32,99 €![Pharmacokinetic Evaluation of Quinine in Herbal Extract Formulation]( "Pharmacokinetic Evaluation of Quinine in Herbal Extract Formulation")
Pharmacokinetic Evaluation of Quinine in Herbal Extract Formulation36,99 €![Formulation and Evaluation of Gastroretentive Drug Delivery System]( "Formulation and Evaluation of Gastroretentive Drug Delivery System")
Formulation and Evaluation of Gastroretentive Drug Delivery System51,99 €
The aim of this research was to formulate and evaluate in-situ liquid depot from bio-degradable polymers like PLGA 85:15 and PLGA 50:50.Isoniazid is a drug of choice for the treatment of tuberclosis. It requires prolong therapy, it has very short half life (Fast acetylators) of 1.1 + 0.1 to 2-3 hrs. Isoniazid is readily absorbed orally and penetrates all body tissues; it is extensively metabolized in liver, most important pathway being acetylation metabolites are excreted in urine. The developed Isoniazid Insitu liquid depot was characterized for percent drug content (PDC), drug polymer interaction study, viscosity, and drug release study. The results of the study showed there were no interaction in drug and polymers after formulation, viscosity was found in all formulation between 1.02 to 1.57 poise and drug content was found to be very between 92.39 + 0.47% to 97.15 + 0.31%. It was found that the amount of drug released at after 168 hours was greater from PLGA 85:15 depots systems formulations as compared to PLGA 50:50 biodegradable liquid depot injections. The results of the characterization and evaluation of in-situ liquid depot established the safety for use and suitability.